关注
Kota Vidyasagar
Kota Vidyasagar
Research Officer, George Institute for Global Health
在 georgeinstitute.org.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India: a systematic review and meta-analysis
AS Bhagavathula, K Vidyasagar, M Chhabra, M Rashid, R Sharma, ...
Frontiers in pharmacology 12, 685518, 2021
362021
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized phase II/III trials
AS Bhagavathula, K Vidyasagar, W Tesfaye
Pharmaceuticals 14 (10), 991, 2021
352021
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis …
S Chenchula, K Vidyasagar, S Pathan, S Sharma, MR Chavan, ...
Scientific reports 13 (1), 6415, 2023
262023
The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an …
C Santenna, K Vidyasagar, KC Amarneni, SN Ghanta, B Sadasivam, ...
Therapeutic Advances in Drug Safety 12, 20420986211042517, 2021
242021
Potentially inappropriate medication use in older hospitalized patients with type 2 diabetes: a Cross-Sectional Study
R Sharma, M Chhabra, K Vidyasagar, M Rashid, D Fialova, ...
Pharmacy 8 (4), 219, 2020
222020
Hepatocellular carcinoma recurrence and mortality rate post liver transplantation: meta-analysis and systematic review of real-world evidence
KI Bzeizi, M Abdullah, K Vidyasagar, SA Alqahthani, D Broering
Cancers 14 (20), 5114, 2022
152022
Knowledge and attitude towards HIV/AIDS in India: A systematic review and meta-analysis of 47 studies from 2010-2020
AS Bhagavathula, CCT Clark, R Sharma, M Chhabra, K Vidyasagar, ...
Health promotion perspectives 11 (2), 148, 2021
152021
Sweetened beverage consumption and risk of cardiovascular mortality: a systematic review and meta-analysis
AS Bhagavathula, J Rahmani, K Vidyasagar, W Tesfaye, J Khubchandani
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (4), 102462, 2022
132022
Organic food consumption and risk of obesity: a systematic review and meta-analysis
AS Bhagavathula, K Vidyasagar, J Khubchandani
Healthcare 10 (2), 231, 2022
112022
Polypharmacy and hyperpolypharmacy in older individuals with Parkinson’s disease: a systematic review and meta-analysis
AS Bhagavathula, W Tesfaye, K Vidyasagar, D Fialova
Gerontology 68 (10), 1081-1090, 2022
112022
Tezepelumab for patients with severe uncontrolled asthma: a systematic review and meta-analysis
Z Zoumot, N Al Busaidi, W Tashkandi, AA Aljohaney, S Isse, K Vidyasagar, ...
Journal of Asthma and Allergy, 1665-1679, 2022
112022
Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis. Front Pharmacol …
AS Bhagavathula, K Vidyasagar, M Chhabra, M Rashid, R Sharma, ...
92021
Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies
M Chhabra, K Vidyasagar, SK Gudi, J Sharma, R Sharma, M Rashid
Plos one 17 (7), e0269531, 2022
72022
Phosphodiesterase type 5 inhibitors use and risk of colorectal cancer: a systematic review and meta-analysis
AS Bhagavathula, W Tesfaye, K Vidyasagar
International Journal of Colorectal Disease, 1-8, 2021
62021
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis
C Carcel, F Haghdoost, J Shen, P Nanda, Y Bai, E Atkins, ...
Cephalalgia 43 (6), 03331024231183166, 2023
52023
Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants
AS Bhagavathula, B Woolf, J Rahmani, K Vidyasagar, W Tesfaye
European Journal of Clinical Pharmacology 78 (4), 547-555, 2022
42022
Efficacy and safety of commonly used insulin analogues in the treatment of diabetic ketoacidosis: a bayesian indirect treatment comparison
K Vidyasagar, B Chandrasekar, M Chhabra, A Bhansali, D Bansal
Clinical Therapeutics 42 (8), e115-e139, 2020
42020
Pattern, severity, and outcome of adverse drug reactions in a tertiary care hospital: an evidence from a cross-sectional study
M Chhabra, MS Jangra, M Rashid, P Sharma, K Vidyasagar
Journal of Basic and Clinical Physiology and Pharmacology 33 (6), 815-822, 2022
32022
Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension
R Kanukula, R Dhurjati, K Vidyasagar, N Rehana, A Talari, A Salam, ...
BMJ Evidence-Based Medicine 27 (2), 79-86, 2022
32022
Quality of the Indian clinical practice guidelines for the management of cardiovascular conditions
R Dhurjati, V Sagar, R Kanukula, N Rehana, PP Mohanan, MD Huffman, ...
JRSM open 13 (12), 20542704221127178, 2022
12022
系统目前无法执行此操作,请稍后再试。
文章 1–20